Skip to main content
    V

    Vivani Medical Inc. (VANI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.15
    -0.01 (-0.86%)

    Market Cap: $104.64M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(22/33)
    Avg Surprise
    +9.48%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.09
    Range$-0.09 - $-0.09
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.090.0%
    60d ago$-0.090.0%
    30d ago$-0.08-8.0%
    7d ago$-0.08-8.0%
    Current$-0.09
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.08
    Range$-0.08 - $-0.08
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.08---
    Sep 26EST
    		-$-0.09---
    Jun 26
    Reported Aug 13
    		$-0.07$-0.08+12.50%Beat+41.7%
    Mar 26
    Reported May 13
    		$-0.08$-0.08+0.00%Beat+24.1%
    Dec 25
    Reported Mar 26
    		$-0.09$-0.10+5.26%Beat+18.2%
    Sep 25
    Reported Nov 13
    		$-0.11$-0.11+0.00%Beat+0.0%
    Jun 25
    Reported Aug 13
    		$-0.12$-0.10-20.00%Miss-20.0%
    Mar 25
    Reported May 13
    		$-0.11$-0.12+12.17%Beat+12.2%
    Dec 24
    Reported Mar 31
    		$-0.11$-0.11+0.00%Beat+8.3%
    Sep 24
    Reported Nov 13
    		$-0.11$-0.10-10.00%Miss+15.4%
    Jun 24
    Reported Aug 13
    		$-0.10$-0.12+16.67%Beat+23.1%
    Mar 24
    Reported May 13
    		$-0.12$-0.12+0.00%Beat+0.0%
    Dec 23
    Reported Mar 26
    		$-0.12$-0.14+14.29%Beat+33.3%
    Sep 23
    Reported Nov 14
    		$-0.13$-0.13+0.00%Beat-451.4%
    Jun 23
    Reported Aug 14
    		$-0.13$-0.11-18.18%Miss-62.5%
    Mar 23
    Reported May 15
    		$-0.12$-0.12+0.00%Beat-100.0%
    Dec 22
    Reported Mar 31
    		$-0.18$0.00N/AMiss-200.0%
    Sep 22
    Reported Nov 14
    		$0.04$0.00N/ABeat+161.7%
    Jun 22
    Reported Jul 4
    		$-0.08N/AN/ABeat-33.3%
    Mar 22
    Reported May 19
    		$-0.06N/AN/ABeat+0.0%
    Dec 21
    Reported Mar 28
    		$-0.06$-0.04-50.00%Miss+0.0%
    Sep 21
    Reported Nov 12
    		$-0.06N/A+82.86%Beat+71.4%
    Jun 21
    Reported Aug 10
    		$-0.06N/A+82.86%Beat+86.7%
    Mar 21
    Reported May 12
    		$-0.06N/A+86.36%Beat+96.5%
    Dec 20
    Reported Mar 16
    		$-0.06N/A+85.71%Beat+96.0%
    Sep 20
    Reported Nov 12
    		$-0.21$-0.41+48.78%Beat+85.4%
    Jun 20
    Reported Aug 13
    		$-0.45N/A+63.41%Beat+73.2%
    Mar 20
    Reported Jun 26
    		$-1.71$-1.23-39.02%Miss+10.9%
    Dec 19
    Reported Mar 19
    		$-1.50$-1.47-2.04%Miss+47.9%
    Sep 19
    Reported Nov 14
    		$-1.44$-1.44+0.00%Beat+50.0%
    Jun 19
    Reported Aug 6
    		$-1.68$-1.44-16.67%Miss+41.7%
    Mar 19
    Reported May 15
    		$-1.92$-1.44-33.33%Miss-71.4%
    Dec 18
    Reported Mar 13
    		$-2.88$-2.64-9.09%Miss+7.7%
    Sep 18
    Reported Nov 7
    		$-2.88$-3.36+14.29%Beat-227.3%
    Jun 18
    Reported Aug 7
    		$-2.88$-3.36+14.29%Beat+0.0%
    Mar 18
    Reported May 10
    		$-1.12N/AN/ABeat+70.8%
    Dec 17
    Reported Mar 7
    		$-3.12$-3.36+7.14%Beat+45.8%
    Sep 17
    Reported Nov 2
    		$-0.88N/AN/ABeat-
    Jun 17
    Reported Aug 1
    		$-2.88$-3.60+20.00%Beat-
    Mar 17
    Reported May 3
    		$-3.84$-3.36-14.29%Miss-
    Dec 16
    Reported Mar 9
    		$-5.76$-4.08-41.18%Miss-

    Key Metrics

    Valuation
    P/E Ratio-3.29EV/EBITDAN/A
    Price/FCF-3.78xFCF Yield-26.46%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-220.40%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio3.25xQuick Ratio3.25x
    Trading Statistics
    Beta3.30Avg Volume177.03K
    52-Week High$1.9252-Week Low$0.92

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.21
    SMA 20$1.22
    SMA 50$1.31
    SMA 200$1.26
    EMA 10$1.20
    EMA 20$1.23
    EMA 50$1.27
    EMA 200$1.28

    MACD

    Line: -0.03Signal: -0.03Hist: -0.00

    ADX

    ADX: 11.6+DI: 18.5-DI: 22.5

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down100.0
    PSAR$1.32

    Bollinger Bands

    Upper Band$1.29
    Lower Band$1.16
    %B Position1077%(Upper)
    Band Width-0.05

    RSI (14-Day)

    Neutral
    36.3

    Momentum Oscillators

    Stoch %K3.8
    Stoch %D8.4
    Williams %R-100.0
    ROC (10d)-5.7%
    Momentum-0.07
    CCI (20d)-199.6
    MFI (14d)36.0

    Volatility Measures

    ATR (14d)$0.05(4.6%)
    StdDev (20d)0.03
    Hist Vol34.9%(Moderate)

    Volume Flow

    VWAP$1.16
    OBV21.3M
    AD Line69.0K
    CMF (20d)-0.336

    Volume Metrics

    Avg Vol (20d)176.6K
    Vol Ratio0.6x
    VWMA (20d)$1.22

    Pivot Points

    R3$1.20
    R2$1.19
    R1$1.18
    Pivot Point$1.17
    S1$1.15
    S2$1.14
    S3$1.13

    Advanced Oscillators

    TSI-17.00
    Ultimate Osc32.2
    KST-74.67

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$398,000$0$0$0$518,000$0
    Cost of Revenue$0$0$115,000$0$0$0$89,000$0$0$0$98,000$0
    Gross Profit$0$0$-115,000$0$0$0$-89,000$0$0$0$-98,000$0
    Operating Expenses$6.87M$6.78M$6.81M$6.72M$7.46M$6.56M$6.46M$6.31M$5.68M$6.23M$6.22M$7.14M
    R&D$4.46M$4.39M$4.63M$4.52M$4.76M$4.22M$4.30M$4.20M$3.51M$3.73M$4.71M$4.44M
    SG&A$2.42M$2.43M$2.18M$2.21M$2.70M$2.34M$2.16M$2.11M$2.17M$2.50M$1.51M$2.70M
    Operating Income$-6,874,000$-6,817,000$-6,812,000$-6,725,000$-7,462,000$-6,557,000$-6,460,000$-6,309,000$-5,681,000$-6,227,000$-6,217,000$-7,144,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-6,370,000$-6,817,000$-5,865,000$-6,725,000$-7,462,000$-6,302,000$-5,457,000$-6,309,000$-5,681,000$-6,039,000$-6,217,000$-7,144,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,370,000$-6,780,000$-6,633,000$-6,530,000$-7,144,000$-6,302,000$-6,050,000$-6,041,000$-5,356,000$-6,039,000$-6,026,000$-6,782,000
    EBITDA$-6,242,000$-6,687,000$-6,697,000$-6,620,000$-7,360,000$-6,200,000$-6,371,000$-6,197,000$-5,508,000$-5,858,000$-6,044,000$-6,372,000
    EBIT$-6,370,000$-6,817,000$-6,812,000$-6,725,000$-7,462,000$-6,302,000$-6,460,000$-6,309,000$-5,681,000$-6,039,000$-6,217,000$-7,144,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VANI

    News

    Vivani Medical Announces Participation in Upcoming Investor Conferences

    Vivani Medical, Inc. (Nasdaq: VANI), a clinical-stage biopharmaceutical company, announced its participation in two upcoming investor conferences: the Maxim Growth Summit on October 14, 2026...

    GlobeNewswire•10/12/26•Bullish

    Vivani Medical Inc. (NASDAQ: VANI) Share Price, VANI Stock News, VANI Share Price & Updates

    Vivani Medical Inc. (NASDAQ: VANI) is a clinical-stage biopharmaceutical company developing miniaturized subdermal drug implants for chronic diseases using its NanoPortal technology. The company's pipeline includes...

    Kalkine•9/29/26•Neutral

    Form 424B5 Vivani Medical Inc For: 25 September By Investing.com

    This article reports on the filing of Form 424B5 by Vivani Medical Inc. for September 25. The brief announcement was published on Investing.com, a financial markets platform.

    Investing.com India•9/26/26•Neutral

    Form 424B5 Vivani Medical Inc For: 25 September By Investing.com

    This article from Investing.com reports on a Form 424B5 filing by Vivani Medical Inc. for September 25th. The brief piece includes the company's stock symbol and its percentage change. It appears to be a standard...

    Investing.com UK•9/25/26•Neutral

    Vivani Medical announces anticipated October closing of Cortigent merger with ClearOne

    Vivani Medical announced that the merger of its subsidiary Cortigent with ClearOne and CLRO Merger Sub is expected to close in October 2026. This comes as Vivani Medical (NASDAQ:VANI) is considered overvalued by...

    Investing.com Nigeria•9/17/26•Neutral

    VANI Valuation and Fair Value

    P/E
    -3.3x
    P/FCF
    -3.8x
    P/B
    5.3x
    See GNG's fair value

    VANI Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -220.4%
    FCF yield
    -26.5%

    VANI Competitors

    CompanyTicker
    Definitive Healthcare CorpDH
    Armata Pharmaceuticals IncARMP
    Genelux Corporation Common StockGNLX
    PDS Biotechnology CorpPDSB
    Stereotaxis IncSTXS
    Unicycive Therapeutics IncUNCY
    enGene Holdings Inc. Common StockENGN
    Inovio Pharmaceuticals IncINO

    Sector: Healthcare

    VANI Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0

    VANI Bull Case vs Bear Case

    Bear case

    • VANI beat EPS estimates in 37.5% of its last 8 reported quarters.

    VANI Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -0.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.09
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About VANI

    Does VANI pay dividends?

    Vivani Medical Inc. (VANI) does not currently pay a regular dividend.

    What is VANI's market cap?

    Vivani Medical Inc. (VANI) has a market capitalization of $104.64M with a current stock price of $1.15.

    Related stocks

    Sector: Healthcare

    All stocks starting with V

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In